纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2023-06-30 Reata Pharmaceuticals Inc-A 0.32%
2023-06-30 Pacific Biosciences of California Inc 0.31%
2023-06-30 Ultragenyx Pharmaceutical Inc 0.31%
2023-06-30 Vir Biotechnology Inc 0.31%
2023-06-30 Axsome Therapeutics Inc 0.29%
2023-06-30 Cytokinetics Inc 0.29%
2023-06-30 Krystal Biotech Inc 0.29%
2023-06-30 PTC Therapeutics Inc 0.28%
2023-06-30 Insmed Inc 0.27%
2023-06-30 Revolution Medicines Inc 0.27%
2023-06-30 Amphastar Pharmaceuticals Inc 0.26%
2023-06-30 BridgeBio Pharma Inc 0.26%
2023-06-30 Sage Therapeutics Inc 0.26%
2023-06-30 Morphic Holding Inc 0.25%
2023-06-30 Akero Therapeutics Inc 0.24%
2023-06-30 Chinook Therapeutics Inc 0.24%
2023-06-30 Beam Therapeutics Inc 0.23%
2023-06-30 Immunovant Inc 0.23%
2023-06-30 Xenon制药 0.23%
2023-06-30 CureVac NV 0.22%

投资模拟

公告&资料